Feb 15–19, 2027 | Beaver Run Conference Center, Breckenridge, CO, United States
Scientific Organizers:
Saptarsi M. Haldar, Karol E. Watson, and David A Kass
-
Scientific Organizers: Saptarsi M. Haldar, Karol E. Watson, and David A Kass
Saptarsi M. Haldar, MD
Karol E. Watson, MD
University of California, Los Angeles
David A Kass, MD
Johns Hopkins Hospital
***Meeting program subject to change.
Available Formats: = In Person = On DemandMerchandise Options
Registration Options
Monday, February 15, 2027
Tuesday, February 16, 2027
Mechanisms of Incretin Therapy and their CV and Neurological Benefits
Human Genetics at the Intersection of Metabolism and CV Risk
Functional Genomics and Perturbational Screening for Cardiometabolic Target Discovery
Metabolic Drivers of CVD and Implications for Clinical Trial Enrichment
Wednesday, February 17, 2027
Rerouting Metabolic Fuel Flux Utilization across Organs in Cardiometabolic Disease
Skeletal Muscle Myokines and HFpEF
Exercise, Adipose & Metabolic Crosstalk
Single Cell Epigenomics to Reveal Cellular Crosstalk in CV Disease
Immune Modulation of Skeletal Muscle Function and Exercise Adaptation
T Lymphocyte Subsets in Cardiovascular Homeostasis and Response to Cancer Immunotherapy
Thursday, February 18, 2027
Targeting Lean Muscle Mass in Cardiovascular and Metabolic Disease
Heterogeneity in the Cardiovascular Benefits of GLP-1R Agonists: Identifying Treatment Responders Leveraging Novel Phenotyping and Data Science Approach
Novel Nucleic Acid-based Therapeutic Platforms in Cardiovascular and Metabolic Disease
Heart-Brain-Splenic Axis and Control of Heart Failure and Hypertension
Novel Immune/Neural Mechanisms in Cardiometabolic Disease
Central Mechanisms Underlying Synergistic Effects of Weight Loss Drugs
Friday, February 19, 2027
Obesity + HFpEF = Bad Sarcomeres
Novel Insights from the DPPOS Cohort
Novel Approaches to Treating Obesity and Adiposity-Related Diseases
Hypoxic Signaling and Interorgan Crosstalk in Physiology & Disease
Insulin Signaling, Mitochondria and Metabolic Heart Disease
Novel Peptides as Obesity Therapeutic Targets
Cardiometabolic-Hepatic Crosstalk
Saturday, February 20, 2027
Subscribe for Updates